Drug Research
Accelerating Drug Development Through CDMO Partnerships
Based on current market analyses, global pharmaceutical spending is projected to reach approximately $1,742 billion by 2025. Concurrently, spending on COVID-19 vaccines and therapeutics...
News
Prefilled Syringes Market Surges To $18.43 Billion In 2023
The global market for prefilled syringes reached a value of USD 18.43 billion in 2023 and is expected to experience a compound annual growth...
News
Takeda Reiterates the Need of Equitable Access to Healthcare for Universal Impact
Takeda Biopharmaceuticals India Private Limited (formerly Baxalta Bioscience India Pvt Ltd) – a global values-based, R&D-driven biopharmaceutical leader in innovative healthcare solutions presented an...
Drug Research
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance
Samsung Biologics announced a new agreement with Bristol Myers Squibb for large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance.
Bristol Myers...
News
Pistoia Alliance Enables Instant, Secure Transfer of Analytical Methods and Results Data Ahead of FDA Guidance
The Pistoia Alliance has announced an industry first for its Methods Hub project; the cloud-based collaborative tool now enables the instant transfer and overlaying...
News
ST Pharm breaks ground on 2nd oligonucleotide manufacturing plant
ST Pharm said it has taken its first step towards becoming the global leader in the oligonucleotide contract development and manufacturing organization (CDMO) domain...
Drug Research
As Lonza CEO departs, Catalent scoops up rival CDMO’s bioscience business head to lead biologics
Mere hours after it surfaced that Lonza’s CEO, Pierre-Alain Ruffieux, will step down, the Swiss CDMO has lost another major executive. And this time,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read